The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers

<p>Head and neck cancer (HNC) is the sixth most common cancer type, accounting for approximately 277,597 deaths worldwide. Recently, the Food and Drug Administration (FDA) has approved immune checkpoint blockade (ICB) agents targeting programmed death-1 (PD-1) and programmed death-ligand 1 (PD...

Full description

Saved in:

Bibliographic Details
Main Author:	Sarra Mestiri (14557379) (author)
Other Authors:	Dina Moustafa Abo El-Ella (18394866) (author), Queenie Fernandes (14557388) (author), Takwa Bedhiafi (14153460) (author), Salam Almoghrabi (15263539) (author), Shayista Akbar (14442117) (author), Varghese Inchakalody (15263530) (author), Laila Assami (17821421) (author), Shaheena Anwar (19325623) (author), Shahab Uddin (154400) (author), Abdul Rehman Zar Gul (14442126) (author), Mariam Al-Muftah (365985) (author), Maysaloun Merhi (4246147) (author), Afsheen Raza (492657) (author), Said Dermime (79420) (author)
Published:	2024
Subjects:	Biomedical and clinical sciences Clinical sciences Immunology Oncology and carcinogenesis Head and neck cancer Immune checkpoint molecules Stimulatory and inhibitory biomarkers Diagnosis And prognosis biomarkers
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers

Similar Items